Arovella Therapeutics
€0.06
0
+€0.01+34.15% Friday 10:16
Statistics
Day High
0.06
Day Low
0.06
52W High
0.06
52W Low
0.03
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
19FebExpected
Expected EPS
-0.0022667817
Actual EPS
-0.00090671268
People Also Follow
This list is based on the watchlists of people on Stock Events who follow E4NA.STU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Arovella Therapeutics Limited, a biotechnology company, engages in the development of therapies for the treatment of cancer in Australia and internationally. It product pipeline includes ALA-101 CD19, which is a next-generation off-the-shelf CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukaemias; ALA-105 CLDN18.2 for targeting Claudin 18.2, which is expressed in gastric cancer, gastroesophageal junction cancer, pancreatic cancer, and lung and ovarian cancer; and IL-12-TM for treating solid tumors. The company was formerly known as Suda Pharmaceuticals Ltd and changed its name to Arovella Therapeutics Limited in October 2021. Arovella Therapeutics Limited was incorporated in 1999 and is based in Preston, Australia.
Show more...
CEO
Dr. Michael Baker
Country
Australia
ISIN
AU0000182784
Listings
0 Comments
Share your thoughts
FAQ
What is Arovella Therapeutics stock price today?▼
The current price of E4NA.STU is €0.06 EUR — it has increased by +34.15% in the past 24 hours. Watch Arovella Therapeutics stock price performance more closely on the chart.
What is Arovella Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Arovella Therapeutics stocks are traded under the ticker E4NA.STU.
Is Arovella Therapeutics stock price growing?▼
E4NA.STU stock has risen by +37.5% compared to the previous week, the month change is a +30.95% rise, over the last year Arovella Therapeutics has showed a +46.67% increase.
When is the next Arovella Therapeutics earnings date?▼
Arovella Therapeutics is going to release the next earnings report on September 02, 2026.
What were Arovella Therapeutics earnings last quarter?▼
E4NA.STU earnings for the last quarter are -0 EUR per share, whereas the estimation was -0 EUR resulting in a +60% surprise. The estimated earnings for the next quarter are N/A EUR per share.
In which sector is Arovella Therapeutics located?▼
Arovella Therapeutics operates in the Health & Wellness sector.
When did Arovella Therapeutics complete a stock split?▼
Arovella Therapeutics has not had any recent stock splits.
Where is Arovella Therapeutics headquartered?▼
Arovella Therapeutics is headquartered in Preston, Australia.